Cerebiome® Receives Frost & Sullivan 2021 Best Practices Award

Frost & Sullivan has identified Cerebiome® by Lallemand Health Solutions as the world’s most proven psychobiotic, a major differentiator compared to competitors in the probiotics for mental health space. Lallemand Health Solutions has earned Frost & Sullivan’s 2021 Product Leadership Award in the European psychobiotics industry, recognizing Cerebiome®’s ability to deliver the best quality, reliability, overall performance, and strong market positioning.

“Frost & Sullivan applies a rigorous analytical process to evaluate multiple nominees for each award category before determining the final award recipient. The process involves a detailed evaluation of best practices criteria across two dimensions for each nominated company. Lallemand Health Solutions excels in many of the criteria in the psychobiotics space”, confirms Arun Ramesh, Research Manager from Frost & Sullivan.

“We are proud that our pioneering and strongly documented psychobiotic Cerebiome® has been awarded by the industry. This confirms the great work done by our talented teams in research, marketing and regulatory affairs. This award gives our clients another argument to use Cerebiome®, the only psychobiotic with validated health claims in Canada and Brazil for its positive impact on mood, stress, and stress-related gut discomfort.” expressed Isabelle Champié, Vice-President, Sales and Marketing at Lallemand Health Solutions.

According to Frost & Sullivan, Lallemand Health Solutions’ innovative ingredient and its various finished formulations stands out.

“Frost & Sullivan observes the company’s commitment to giving back to society is phenomenal, differentiating it from many other firms in the market.”, adds Ramesh.

Access the full Frost & Sullivan’s report as well as a large amount of information on the power of psychobiotics on the dedicated website https://cerebiomebylallemand.com/

About Cerebiome®

Lallemand Health Solutions’ flagship formulation Cerebiome®, a proprietary combination of L. helveticus Rosell®-52 and B. longum Rosell®-175 is a unique and strongly documented psychobiotic formulation developed by the Rosell® Institute for Microbiome and Probiotics by Lallemand. It is the most documented psychobiotic, supported by five clinical studies and over ten mechanistic studies, highlighting eight mechanisms of action on the brain-gut axis. Cerebiome® helps alleviate the physical and psychological symptoms of stress and feelings of anxiety. To find out more about Cerebiome®, an innovative ingredient, visit cerebiomebylallemand.com and download the White paper to explore the power of psychobiotics.

About Lallemand Health Solutions

Lallemand Health Solutions is a vertically integrated probiotic manufacturer specialized in the research, development and manufacturing of best-in-class, ready-to-market and custom probiotic formulations. Its products target specific populations and health segments including gut health, immune health, mental health, women’s health, skin health, oral health, sport and metabolism. Its probiotics are produced in cutting-edge manufacturing facilities certified to the highest quality. More than 600 probiotic formulas are currently marketed in over 60 countries across five continents. Lallemand Health Solutions is proud to have an open culture of entrepreneurial spirit and is pursuing a never-ending quest to look out for better ways to improve quality, productivity and to create innovative products.

About Frost & Sullivan

Frost & Sullivan is the Growth Pipeline Company™. We power our clients to a future shaped by growth. Our Growth Pipeline as a Service™ provides the CEO and the CEO’s growth team with a continuous and rigorous platform of growth opportunities, ensuring long-term success. To achieve positive outcomes, our team leverages over 60 years of experience, coaching organizations of all types and sizes across 6 continents with our proven best practices. To power your Growth Pipeline future, visit Frost & Sullivan at https://www.frost.com.

̶̶̶ 30 ̶̶

 

MEDIA CONTACT Marilou Luneau, Content Manager, Lallemand Health Solutions, mluneau@lallemand.com